Comparison Overview

RRD Biopharma Development, a Uniphar Company

VS

Talecris Plasma Resources

RRD Biopharma Development, a Uniphar Company

700 King Farm Blvd, Rockville, Maryland, 20850, US
Last Update: 2025-05-04 (UTC)
Between 800 and 900
http://www.rrdbiodev.com

Strong

RRD Biopharma Development is a drug development company with an alternative approach to achieving human-proof-of-concept (hPOC) that is intensely focused on minimizing time, risk, and cost while maximizing efficiency and probability of success. RRD’s Product Development Team (PDT) model is ideal for companies interested in an asset-centric capital approach that can accelerate an hPOC value inflection as efficiently as possible while enabling the development of high-quality, pharmaceutical-grade data packages required by regulators and potential biopharma partners. The PDT model provides our partners with a “plug and play”, high-caliber, and highly experienced drug development team that can be deployed immediately. Time and resources are not needlessly spent assembling the right development team or enduring consultant hand-offs on the front end, which can absorb 18 months or more, with no guarantee of coalescence, while impacting exclusivity and revenue on the back end. Paying for this learning curve is expensive. Together with our partners, we tailor strategies designed to optimize product value to a defined stage of development and then direct and manage execution of that strategy towards optimizing outcomes. Learn more about us at www.rrdbiodev.com

NAICS: 541714
NAICS Definition: Research and Development in Biotechnology (except Nanobiotechnology)
Employees: 86
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Talecris Plasma Resources

None
Last Update: 2025-05-06 (UTC)

Strong

Between 800 and 900
https://www.grifolsplasma.com

Talecris Plasma Resources was established in 2006 to ensure a reliable and safe supply of plasma for the production of premium protein therapies that help save and enhance lives worldwide. Today, we are a nationwide network of 69 plasma collection centers guided by our unwavering commitment to safety, quality and excellence.

NAICS: 541714
NAICS Definition: Research and Development in Biotechnology (except Nanobiotechnology)
Employees: 10,001+
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/rrd-international-llc.jpeg
RRD Biopharma Development, a Uniphar Company
—
ISO 27001
Not verified
—
SOC 2
Not verified
—
GDPR
No public badge
—
PCI DSS
No public badge
https://images.rankiteo.com/companyimages/defaultcompany.jpeg
Talecris Plasma Resources
—
ISO 27001
Not verified
—
SOC 2
Not verified
—
GDPR
No public badge
—
PCI DSS
No public badge
Compliance Summary
RRD Biopharma Development, a Uniphar Company
100%
Compliance Rate
0/4 Standards Verified
Talecris Plasma Resources
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Biotechnology Research Industry Average (This Year)

No incidents recorded for RRD Biopharma Development, a Uniphar Company in 2025.

Incidents vs Biotechnology Research Industry Average (This Year)

No incidents recorded for Talecris Plasma Resources in 2025.

Incident History — RRD Biopharma Development, a Uniphar Company (X = Date, Y = Severity)

RRD Biopharma Development, a Uniphar Company cyber incidents detection timeline including parent company and subsidiaries

Incident History — Talecris Plasma Resources (X = Date, Y = Severity)

Talecris Plasma Resources cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/rrd-international-llc.jpeg
RRD Biopharma Development, a Uniphar Company
Incidents

No Incident

https://images.rankiteo.com/companyimages/defaultcompany.jpeg
Talecris Plasma Resources
Incidents

No Incident

FAQ

Both RRD Biopharma Development, a Uniphar Company company and Talecris Plasma Resources company demonstrate a comparable AI risk posture, with strong governance and monitoring frameworks in place.

Historically, Talecris Plasma Resources company has disclosed a higher number of cyber incidents compared to RRD Biopharma Development, a Uniphar Company company.

In the current year, Talecris Plasma Resources company and RRD Biopharma Development, a Uniphar Company company have not reported any cyber incidents.

Neither Talecris Plasma Resources company nor RRD Biopharma Development, a Uniphar Company company has reported experiencing a ransomware attack publicly.

Neither Talecris Plasma Resources company nor RRD Biopharma Development, a Uniphar Company company has reported experiencing a data breach publicly.

Neither Talecris Plasma Resources company nor RRD Biopharma Development, a Uniphar Company company has reported experiencing targeted cyberattacks publicly.

Neither RRD Biopharma Development, a Uniphar Company company nor Talecris Plasma Resources company has reported experiencing or disclosing vulnerabilities publicly.

Neither RRD Biopharma Development, a Uniphar Company company nor Talecris Plasma Resources company has publicly disclosed detailed information about the number of their subsidiaries.

RRD Biopharma Development, a Uniphar Company company employs more people globally than Talecris Plasma Resources company, reflecting its scale as a Biotechnology Research.

Latest Global CVEs (Not Company-Specific)

Description

Improper Protection Against Voltage and Clock Glitches in FPGA devices, could allow an attacker with physical access to undervolt the platform resulting in a loss of confidentiality.

Published
Date
2025-09-24
Updated
Date
2025-09-24
Risk Information
cvss4
Base: 8.6
Severity: LOW
CVSS:4.0/AV:P/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

Malicious code was inserted into the Nx (build system) package and several related plugins. The tampered package was published to the npm software registry, via a supply-chain attack. Affected versions contain code that scans the file system, collects credentials, and posts them to GitHub as a repo under user's accounts.

Published
Date
2025-09-24
Updated
Date
2025-09-24
Risk Information
cvss3
Base: 9.6
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:H/I:H/A:H
References
Description

Flag Forge is a Capture The Flag (CTF) platform. In versions from 2.1.0 to before 2.3.0, the API endpoint GET /api/problems/:id returns challenge hints in plaintext within the question object, regardless of whether the user has unlocked them via point deduction. Users can view all hints for free, undermining the business logic of the platform and reducing the integrity of the challenge system. This issue has been patched in version 2.3.0.

Published
Date
2025-09-24
Updated
Date
2025-09-24
Risk Information
cvss3
Base: 7.5
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
References
Description

Flag Forge is a Capture The Flag (CTF) platform. In version 2.1.0, the /api/admin/assign-badge endpoint lacks proper access control, allowing any authenticated user to assign high-privilege badges (e.g., Staff) to themselves. This could lead to privilege escalation and impersonation of administrative roles. This issue has been patched in version 2.2.0.

Published
Date
2025-09-24
Updated
Date
2025-09-24
Risk Information
cvss3
Base: 8.2
Severity: LOW
CVSS:3.0/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:H/A:N
References
Description

parse is a package designed to parse JavaScript SDK. A Prototype Pollution vulnerability in the SingleInstanceStateController.initializeState function of parse version 5.3.0 and before allows attackers to inject properties on Object.prototype via supplying a crafted payload, causing denial of service (DoS) as the minimum consequence.

Published
Date
2025-09-24
Updated
Date
2025-09-24
References